Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)

NCT03948646 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

Axillary Hyperhidrosis

Interventions

DRUG: Sofpironium Bromide, 15%
DRUG: Vehicle

Sponsor

Botanix Pharmaceuticals